Please use this identifier to cite or link to this item: https://ninho.inca.gov.br/jspui/handle/123456789/10019
Full metadata record
DC FieldValueLanguage
dc.contributor.authorInstituto Nacional de Câncer José Alencar Gomes da Silva-
dc.contributor.authorInstituto Nacional de Câncer (Brasil)-
dc.contributor.authorINCA-
dc.date.accessioned2022-08-12T18:38:32Z-
dc.date.available2022-08-12T18:38:32Z-
dc.date.issued2016-08-
dc.identifier.urihttp://sr-vmlxaph03:8080/jspui/handle/123456789/10019-
dc.publisherINCApt_BR
dc.subjectBiofarmáciapt_BR
dc.subjectBiopharmaceuticspt_BR
dc.subjectBiofarmaciapt_BR
dc.subjectParcerias Público-Privadaspt_BR
dc.subjectPublic-Private Sector Partnershipspt_BR
dc.subjectAsociación entre el Sector Público-Privadopt_BR
dc.subjectInstitutos de Câncerpt_BR
dc.subjectCancer Care Facilitiespt_BR
dc.subjectInstituciones Oncológicaspt_BR
dc.titleINCA e AstraZeneca formam parceria para pesquisa em câncerpt_BR
dc.title.alternativeInforme INCA 350pt_BR
dc.TypeArticlept_BR
Appears in Collections:Informe INCA 350

Files in This Item:
File Description SizeFormat 
Informe-INCA-2016-350-9-INCA-e-AstraZeneca.pdf247.93 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.